Pyxis Oncology
PYXS
PYXS
99 hedge funds and large institutions have $49.2M invested in Pyxis Oncology in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
8% more funds holding
Funds holding: 92 → 99 (+7)
6.13% more ownership
Funds ownership: 46.93% → 53.06% (+6.1%)
52% less capital invested
Capital invested by funds: $102M → $49.2M (-$53.1M)
Holders
99
Holding in Top 10
4
Calls
$1.59M
Puts
$80K
Top Buyers
| 1 | +$1.68M | |
| 2 | +$1.35M | |
| 3 | +$653K | |
| 4 |
BlackRock
New York
|
+$593K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$342K |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$4.13M | |
| 3 | -$3.12M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.01M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$826K |